Blood Components as Carriers for Small‐Molecule Platinum Anticancer Drugs
Sign Up to like & getrecommendations! Published in 2022 at "ChemMedChem"
DOI: 10.1002/cmdc.202200482
Abstract: The efficacy of platinum drugs is limited by severe side effects, drug resistance, and poor pharmacokinetic properties. Utilizing long‐lasting blood components as drug carriers is a promising strategy to improve the circulation half‐lives and tumor… read more here.
Keywords: small molecule; platinum drugs; blood components; molecule platinum ... See more keywords